Clinical Trial Update: Apixaban for Extended Anticoagulation (APIDULCIS) [Phase 4]

View source ↗

Summary

Phase 4 trial update for apixaban in extended anticoagulation (APIDULCIS) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Arianna Anticoagulazione Foundation | Conditions: Venous Thromboembolism, Anticoagulants | Phase 4 | Status: TERMINATED